At present, the diagnosis of CML is mainly based on an increased number of immature leukocytes in peripheral blood and the identification of the Ph chromosome, as well as the qualitative detection of BCR-ABL1 gene by PCR [20]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.